RMED - Ra Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 525.73M
Enterprise Value 3-23.99M
Trailing P/E N/A
Forward P/E 1-0.88
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.66
Price/Book (mrq)0.43
Enterprise Value/Revenue 3-3.41
Enterprise Value/EBITDA 60.56

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 32.36%
52 Week High 322.0000
52 Week Low 31.0900
50-Day Moving Average 32.7303
200-Day Moving Average 34.1837

Share Statistics

Avg Vol (3 month) 375.39k
Avg Vol (10 day) 3324.45k
Shares Outstanding 5N/A
Float 6.94M
% Held by Insiders 141.98%
% Held by Institutions 132.19%
Shares Short (Jul 31, 2019) 4485.65k
Short Ratio (Jul 31, 2019) 411.61
Short % of Float (Jul 31, 2019) 49.48%
Short % of Shares Outstanding (Jul 31, 2019) 43.76%
Shares Short (prior month Jun 28, 2019) 4499.95k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-617.14%

Management Effectiveness

Return on Assets (ttm)-67.94%
Return on Equity (ttm)-168.26%

Income Statement

Revenue (ttm)7.04M
Revenue Per Share (ttm)0.68
Quarterly Revenue Growth (yoy)80.40%
Gross Profit (ttm)2.05M
EBITDA -42.59M
Net Income Avi to Common (ttm)-42.81M
Diluted EPS (ttm)-4.1090
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)55.13M
Total Cash Per Share (mrq)4.26
Total Debt (mrq)4.11M
Total Debt/Equity (mrq)6.88
Current Ratio (mrq)11.89
Book Value Per Share (mrq)4.66

Cash Flow Statement

Operating Cash Flow (ttm)-25.03M
Levered Free Cash Flow (ttm)-7.4M